85 related articles for article (PubMed ID: 6113891)
1. Prevention of adrenaline-induced metabolic systemic and myocardial alterations by the beta-blocking agent metipranolol in the dog.
Herbaczyńska-Cedro K; Woźniewicz B; Broniszewska-Ardelt B; Ceremuzyński L
Cardiology; 1981; 67(4):206-18. PubMed ID: 6113891
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of insulin-glucose in preventing adrenaline-induced myocardial and systemic disturbances in the dog.
Ceremuzyński L; Herbaczyńska-Cedro K; Wozniewicz B
Jpn Circ J; 1980 Sep; 44(9):740-8. PubMed ID: 6997526
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the detrimental effect of adrenaline infused to healthy dogs in doses imitating spontaneous secretion after coronary occlusion.
Ceremuzyński L; Herbaczyńska-Cedro K; Broniszewska-Ardelt B; Nauman J; Nauman A; Woźniewicz B; Lawecki J
Cardiovasc Res; 1978 Mar; 12(3):179-89. PubMed ID: 25714
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of practolol in preventing adrenaline-induced systemic and myocardial metabolic changes.
Herbaczyńska-Cedro K; Ceremuzyński L; Broniszewska-Ardelt B; Woźniewicz B
Eur J Clin Invest; 1979 Aug; 9(4):309-15. PubMed ID: 118021
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effect of metipranolol on ischemic heart muscle.
Gvozdják J; Gvozdjáková A; Kucharská J; Bada V
Cardiology; 1989; 76(3):206-10. PubMed ID: 2570631
[TBL] [Abstract][Full Text] [Related]
6. [Effect of isosorbide-5-mononitrate, metipranolol and a combination of the two in experimental myocardial ischemia in the awake dog].
Sponer G; Voss E; Dietmann K
Med Welt; 1981 Apr; 32(14A):492-6. PubMed ID: 6113532
[No Abstract] [Full Text] [Related]
7. Effects of beta-blocking agent Metipranolol on metabolic variables in patients with ischemic heart disease, hyperkinetic syndrome, hyperthyreosis and in healthy subjects.
Ceremuzynski L; Zaleska T; Nauman J; Nauman A; Zalewski A
Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):244-9. PubMed ID: 38215
[TBL] [Abstract][Full Text] [Related]
8. Metabolic responses to catecholamines in dogs injected with a single dose of triiodothyronine.
Brzezinska Z; Kaciuba-Uscilko H
Arch Int Physiol Biochim; 1977 Aug; 85(3):487-95. PubMed ID: 72526
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and metabolic effects of metipranolol].
Cottini E; Barbanti P; Lunetta M; Dimaiuta G; Emma V; Sorrentino F
Boll Soc Ital Cardiol; 1981; 26(10):1341-8. PubMed ID: 6129875
[No Abstract] [Full Text] [Related]
10. Prevention of sudden death in acute myocardial ischaemia.
Fejfar Z; Vrána M; Horák O; Trcka V; Kristan L; Blazek Z; Korál V; Sychra T
Czech Med; 1980; 3(1):28-35. PubMed ID: 6102022
[No Abstract] [Full Text] [Related]
11. [Changes in the efficiency of the left heart ventricle during treatment with metipranolol (Trimepranol Spofa)].
Smíd J; Hůla J; Kubín Z
Vnitr Lek; 1983 Apr; 29(4):325-31. PubMed ID: 6135276
[No Abstract] [Full Text] [Related]
12. Metabolic and haemodynamic responses to adrenaline in normal dogs.
Drake AJ; Herbaczynska-Cedro K; Ceremuzynski L; Czarnecki W; Noble MI
Basic Res Cardiol; 1982; 77(2):188-96. PubMed ID: 7092777
[TBL] [Abstract][Full Text] [Related]
13. Dichloroacetate attenuates myocardial acidosis and metabolic changes induced by partial occlusion of the coronary artery in dogs.
Sakai K; Ichihara K; Nasa Y; Kamigaki M; Abiko Y
Arch Int Pharmacodyn Ther; 1990; 307():92-108. PubMed ID: 2095718
[TBL] [Abstract][Full Text] [Related]
14. Plasma catecholamine concentration in hypertensive subjects with chronic renal failure before and during treatment with the beta-receptor blocking drug metipranolol.
Planz G; Haass H; Lamberts B
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):469-73. PubMed ID: 6128312
[TBL] [Abstract][Full Text] [Related]
15. [Coronary therapeutic effectiveness of low-dose IS-5-MN in comparison with the combination IS-5-MH and metipranolol and placebo].
Müller G; Uberbacher HJ; Glocke M
Med Welt; 1983 Mar; 34(10):321-7. PubMed ID: 6133205
[No Abstract] [Full Text] [Related]
16. Failure of beta-blocking agent to prevent epinephrine-induced myocardial injury in dogs with hypokalemia.
Sugiyama S; Takamura T; Hanaki Y; Ajioka M; Nagai S; Ozawa T
Res Commun Chem Pathol Pharmacol; 1988 Dec; 62(3):407-18. PubMed ID: 3222523
[TBL] [Abstract][Full Text] [Related]
17. Studies on experimental coronary insufficiency. II. Effects of beta-adrenergic blocking agent (propranolol) on metabolic response to adrenaline and noradrenaline in dogs with coronary constriction.
Iimura O; Wakabayashi C; Kobayashi T; Shoji T; Yoshida S; Miyahara M
Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():543-7. PubMed ID: 1032009
[TBL] [Abstract][Full Text] [Related]
18. [Antiglaucomatous effectiveness of beta receptor blockers with special reference to metipranolol].
Noack E
Klin Monbl Augenheilkd; 1986 Jul; 189(1):1-3. PubMed ID: 2876128
[TBL] [Abstract][Full Text] [Related]
19. Influence of surgery and experimental myocardial infarction on blood levels of free fatty acids and triiodothyronine in dogs.
Wasilewska-Dziubińska E; Nauman A; Lewartowski B; Nauman J; Michałowski J; Sedek G
Acta Physiol Pol; 1981; 32(3):283-91. PubMed ID: 7304199
[TBL] [Abstract][Full Text] [Related]
20. [Effect of beta-blocking agents talinolol and metipranolol in patients with thyrotoxicosis (author's transl)].
Nedvídková J; Cenková V; Felt V
Cas Lek Cesk; 1980 Jul; 119(27-28):749-51. PubMed ID: 6107177
[No Abstract] [Full Text] [Related]
[Next] [New Search]
